Article
A novel viral vaccine platform based on engineered transfer RNA
9 Dec 2022
Abstract excerpt
In recent years, an increasing number of emerging and remerging virus outbreaks have occurred and the rapid development of vaccines against these viruses has been crucial. Controlling the replication of premature termination codon (PTC)-containing viruses is a promising approach to generate live but replication-defective viruses that can be used for potent vaccines. Here, we used anticodon-engineered transfer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
